{"date":"2025-05-13","count":38,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4728-2025-05-13-1918-1ihuy0a","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"19:18:50","subject":"公告本公司獨立董事對薪酬委員會及董事會決議事項表示保留意見。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2025-05-13 19:18，「公告本公司獨立董事對薪酬委員會及董事會決議事項表示保留意見。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2025-05-13-1915-1ozeh9d","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"19:15:59","subject":"公告本公司114年第一季財務報告業經提報董事會。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2025-05-13 19:15，「公告本公司114年第一季財務報告業經提報董事會。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2025-05-13-1915-qmpqzy","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"19:15:18","subject":"開發中新藥OBP-301進度更新","clause":"第53款","fact_date":"2025-05-13","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2025-05-13 19:15，「開發中新藥OBP-301進度更新」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-05-13-1858-9qofud","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"18:58:07","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-05-13 18:58，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-05-13-1837-dlxzfc","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-13","time":"18:37:46","subject":"公告本公司董事會決議召開114年股東常會(增列討論事項)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-05-13 18:37，「公告本公司董事會決議召開114年股東常會(增列討論事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-05-13-1837-q33ni9","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-13","time":"18:37:20","subject":"公告本公司董事會決議通過113年員工認股權憑證發行日及發行認股價格","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-05-13 18:37，「公告本公司董事會決議通過113年員工認股權憑證發行日及發行認股價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-05-13-1836-3j927o","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-13","time":"18:36:18","subject":"公告本公司董事會決議辦理114年度第一次現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-05-13 18:36，「公告本公司董事會決議辦理114年度第一次現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-05-13-1835-ke1qih","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-13","time":"18:35:19","subject":"公告本公司更換主辦輔導推薦證券商事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-05-13 18:35，「公告本公司更換主辦輔導推薦證券商事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2025-05-13-1834-5rax5d","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-13","time":"18:34:25","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2025-05-13 18:34，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-05-13-1819-59ea2p","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-05-13","time":"18:19:58","subject":"補充公告本公司竹北二期廠房建置及設備擴增案相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-05-13 18:19，「補充公告本公司竹北二期廠房建置及設備擴增案相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2025-05-13-1802-wuwt1i","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"18:02:30","subject":"公告本公司董事會通過114年第一季合併財報","clause":"第31款","fact_date":"2025-05-13","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2025-05-13 18:02，「公告本公司董事會通過114年第一季合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-05-13-1754-agahcd","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-05-13","time":"17:54:45","subject":"公告本公司分派113年度現金股利之基準日","clause":"第31款","fact_date":"2025-05-13","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-05-13 17:54，「公告本公司分派113年度現金股利之基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-05-13-1749-1uaac4g","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"17:49:18","subject":"代子公司共信醫藥科技股份有限公司公告擬投資設立子公司","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-05-13 17:49，「代子公司共信醫藥科技股份有限公司公告擬投資設立子公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2025-05-13-1747-54swv6","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"17:47:58","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2025-05-13","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2025-05-13 17:47，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-05-13-1736-1sny4qm","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"17:36:23","subject":"SNS812新藥二期臨床試驗成果獲選於2025 ATS美國胸腔醫學會進行口頭報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-05-13 17:36，「SNS812新藥二期臨床試驗成果獲選於2025 ATS美國胸腔醫學會進行口頭報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-05-13-1734-wsqazv","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"17:34:23","subject":"公告本公司董事會決議通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-05-13 17:34，「公告本公司董事會決議通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-05-13-1731-fi9lrj","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-05-13","time":"17:31:49","subject":"本公司民國114年第一季合併財務報告業經董事會通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-05-13 17:31，「本公司民國114年第一季合併財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-05-13-1724-nlkpwc","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"17:24:25","subject":"公告本公司董事會決議發行114年度第一次員工認股權憑證及認股辦法","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-05-13 17:24，「公告本公司董事會決議發行114年度第一次員工認股權憑證及認股辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-05-13-1714-339orf","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"17:14:10","subject":"更正本公司背書保證資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-05-13 17:14，「更正本公司背書保證資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-05-13-1713-1v1wt8s","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"17:13:47","subject":"公告本公司取得會計師113年度內部控制專案審查報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-05-13 17:13，「公告本公司取得會計師113年度內部控制專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2025-05-13-1713-9qofud","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"17:13:02","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2025-05-13 17:13，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2025-05-13-1701-1qytcve","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"17:01:09","subject":"公告本公司董事會通過對關係人捐贈事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2025-05-13 17:01，「公告本公司董事會通過對關係人捐贈事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2025-05-13-1700-me7u10","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"17:00:50","subject":"本公司114年第1季合併財務報告經提報董事會通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2025-05-13 17:00，「本公司114年第1季合併財務報告經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-05-13-1659-17up2wc","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-05-13","time":"16:59:24","subject":"公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-05-13 16:59，「公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-05-13-1656-1g0unvq","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-05-13","time":"16:56:33","subject":"公告本公司董事會通過114年第1季合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-05-13 16:56，「公告本公司董事會通過114年第1季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-05-13-1654-1jm8xii","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-05-13","time":"16:54:28","subject":"公告本公司一年內累積處分同一有價證券達實收資本額百分之二十","clause":"第17款","fact_date":"2025-05-13","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-05-13 16:54，「公告本公司一年內累積處分同一有價證券達實收資本額百分之二十」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-05-13-1652-1wm7rif","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-05-13","time":"16:52:18","subject":"公告法人董事指派代表人出席114/05/13董事會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-05-13 16:52，「公告法人董事指派代表人出席114/05/13董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2025-05-13-1631-9qofud","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"16:31:13","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2025-05-13 16:31，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-05-13-1622-1bey2nb","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"16:22:44","subject":"公告本公司庫藏股暨限制員工權利新股收回減資變更登記完成","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-05-13 16:22，「公告本公司庫藏股暨限制員工權利新股收回減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-05-13-1619-9qofud","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-05-13","time":"16:19:54","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-05-13 16:19，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3184-2025-05-13-1609-15tfyua","company_id":"3184","company":"微邦","market":"興櫃","industry":"生技醫療","date":"2025-05-13","time":"16:09:25","subject":"公告本公司董事會決議召開114年股東會相關事宜(新增議案)","clause":"第32款","fact_date":"2025-05-13","cite_as":"公開資訊觀測站重大訊息：微邦（3184），2025-05-13 16:09，「公告本公司董事會決議召開114年股東會相關事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-05-13-1556-tp6b41","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-05-13","time":"15:56:45","subject":"更正本公司1131017核准之現金增資運用情形季報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-05-13 15:56，「更正本公司1131017核准之現金增資運用情形季報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2025-05-13-1550-5rax5d","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-05-13","time":"15:50:11","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-05-13 15:50，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2025-05-13-1549-10co1p5","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-05-13","time":"15:49:59","subject":"睿生光電113年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-05-13 15:49，「睿生光電113年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2025-05-13-1549-c0u8or","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-05-13","time":"15:49:28","subject":"公告本公司財務主管及會計主管真除","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-05-13 15:49，「公告本公司財務主管及會計主管真除」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3184-2025-05-13-1541-ngcpt0","company_id":"3184","company":"微邦","market":"興櫃","industry":"生技醫療","date":"2025-05-13","time":"15:41:07","subject":"公告本公司董事會決議辦理減資彌補虧損案","clause":"第9款","fact_date":"2025-05-13","cite_as":"公開資訊觀測站重大訊息：微邦（3184），2025-05-13 15:41，「公告本公司董事會決議辦理減資彌補虧損案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-05-13-1446-1l17w7x","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"14:46:07","subject":"本公司114年第1季合併財務報告已提報董事會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-05-13 14:46，「本公司114年第1季合併財務報告已提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1777-2025-05-13-1442-pirb3e","company_id":"1777","company":"生泰","market":"上櫃","industry":"生技醫療","date":"2025-05-13","time":"14:42:22","subject":"公告本公司受邀參加元大證券舉辦之線上法說會","clause":"第12款","fact_date":"2025-05-14","cite_as":"公開資訊觀測站重大訊息：生泰（1777），2025-05-13 14:42，「公告本公司受邀參加元大證券舉辦之線上法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}